Mahmood Ahmad
Tahir Heart Institute
author@example.com

Protocol: CT.gov Description-Black-Box Repeaters

This protocol isolates a stricter narrative blackout inside older CT.gov records. A description black-box study is an eligible older closed interventional study with a two-year results gap, no linked publication reference, no detailed description, and no primary outcome description. Primary outputs rank named sponsors with at least 100 older studies by description-black-box stock and rate, then compare sponsor-class summaries.

Outside Notes

Type: protocol
Primary estimand: Description black-box stock among older studies with no results, no linked publication, no detailed description, and no primary outcome description
App: CT.gov Description-Black-Box Repeaters dashboard
Code: https://github.com/mahmood726-cyber/ctgov-description-black-box-repeaters
Date: 2026-03-29
Validation: FULL REGISTRY RUN

References

1. ClinicalTrials.gov API v2. National Library of Medicine. Accessed March 29, 2026.
2. DeVito NJ, Bacon S, Goldacre B. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. Lancet. 2020;395(10221):361-369.
3. Zarin DA, Tse T, Williams RJ, Carr S. Trial reporting in ClinicalTrials.gov. N Engl J Med. 2016;375(20):1998-2004.

AI Disclosure

This work represents a compiler-generated evidence micro-publication built from structured registry data and deterministic summary code. AI was used as a constrained coding and drafting assistant for interface generation, packaging, and prose refinement, not as an autonomous author. The analytical choices, interpretation, and final outputs were reviewed by the author, who takes responsibility for the content.